Implant Biomaterials Market By Material Type (Metal & Alloy Biomaterials, Polymer Biomaterials, Composite Biomaterials, Natural Biomaterials), By Application (Orthopedics, Dental, Ophthalmic, Cardiovascular, Others) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

During the forecast period, the implant biomaterials market will grow at a rapid pace.

The global implant biomaterials market is steadily expanding, with a value of $34.8 billion in 2017 and a projected value of $64.0 billion by 2026. The market is growing due to the increasing global adoption of orthopedic implants, dental and cardiovascular procedures, the use of advanced biomaterials, and the preference for minimally invasive surgeries. Furthermore, rising medical tourism in developing nations, growing healthcare expenditure, swift approval of new advanced biomaterials, and growing demand for customized implants in the dental segment are also fueling the overall implant biomaterials market. New technological developments in CAD/CAM systems, rapid product commercialization, and encouraging public and government initiatives in the prosthetics industry across various countries in Asia Pacific and Europe will further assist in the overall market growth.

Other developments influencing the overall growth include innovation in computer-assisted implant dentistry (the cloud), usage of polymeric biomaterials, and novel formulations in polycarbonate urethanes and silicon. Increasing research and development on nanostructure, biomaterial surface, and coating, improvement in the standardization of the properties of biomaterials, and enhancement in bio-functionalization for future infection prevention are gaining traction in the global market. However, product recalls (medical implants), future risk of foreign body-related infections (FBRIs), implant failures, and post-surgery infections are factors restraining the overall market growth during the forecast period.

Market Synopsis

The composite material type segment is expected to register higher growth by the end of 2026.

The global sales of implant biomaterials for medical devices will experience a progressive impact from increasing technological interventions in the orthopedic and dental industries. The availability of a wide range of products in the global market incorporating bioresorbable polymer technology in stents, natural or synthetic polymers, metal or metal alloys such as titanium and zirconia, and bioactive ceramics showed significant growth during the forecast period. Additionally, the widespread use of bone graft biomaterials and current progress in synthetic graft biomaterials have led to the discovery of the further expansion of ceramic materials, bioactive glass, and porous titanium particles. The increasing demand for customized implants globally in the orthopedic and dental segments is going to spur further revenue growth during the forecast period. Increased applications of advanced biomaterials for joint replacements, modular tumor implants, and spine implants in the orthopedic segment are also generating a significant revenue share in the market.

Increasing applications for orthopedic and dental biomaterials will gain maximum share during the forecast period.

Increasing implant procedures in the cardiovascular, dental, and orthopedic segments, along with high-precision digital mapping technologies, are creating traction in the global market. Utilization of 3D printing technology, consistent new product launches, and usage of implant biomaterials in ophthalmology and drug delivery in developed nations are further going to spur revenue growth during the forecast period. In the dental segment, advancement in new biomaterials such as rooted, zirconia, and surface-modified titanium implants is also showing significant market growth.

Additionally, increased applications in cardiovascular (homograft valves, porcine and bovine valves), implant dentistry, reconstructive surgeries, and bone tissue engineering are also generating a significant revenue share in the market. Overall advancements in medical device components, regenerative medicine, tissue engineering, and collagen and tissue biomaterials applications are assisting the market's overall growth.

A greater prevalence of dental and bone infections and the presence of established players hold North America in a dominant position.

North America contributes the maximum revenue share in the overall implant biomaterials market, which is attributed to increasing orthopedic implant procedures along with the aging population and higher adoption of branded biomaterials. According to an American Dental Association study, overall national dental expenditures in the United States increased from US$ 114 billion in 2014 to around US$ 117 billion in 2015. The high prevalence of oral and dental infection improved care and growing expenditure on oral care, new technology assessment in biomaterials, and increasing awareness and demand for aesthetic restorations in cosmetic dentistry in North America are all factors boosting overall industry growth.

Increasing demand for biomaterials for oral surgery, along with bone graft and membrane materials (bovine, allogeneic, and synthetic bone-graft materials), in developing nations is generating maximum revenue share in the dental industry. However, in the lower-income nations of Africa, Asia, and Latin America, the availability of cardiovascular, orthopedic, and dental treatment is inadequate. Lack of specialized healthcare professionals, less or no expansion of branded products, less awareness, and the high cost of advanced biomaterials, along with no reimbursement, are a few factors restraining the overall growth of the market.

The dominance of multinational manufacturers with strong product portfolios in the developed regions

Major players in the implant biomaterials market are Evonik Industries AG, Celanese Corp., Royal DSM, Invibio, Inc., DuPont, AdvanSource Biomaterials Corp., Collagen Matrix, Inc., Invibio Ltd., Collagen Solutions Plc., Keystone Dental, Inc., Surgical, SBM France, Zimmer Biomet, and others. Topmost manufacturers are executing growth strategies with technology assessments in advanced biomaterials, partnerships with dental hospitals and medical technology companies, and launching new implants with top-quality materials, especially in the orthopedic and dental segments. For instance, in September 2018, Henry Schein, Inc. declared three investments that would enhance the growth of the company. Henry Schein acquired Intra-Lock (a provider of dental restoration solutions, including proprietary surfaces, connections, biomaterials, and small-diameter implant technologies) and Medentis Medical (a dental implant manufacturer) to further strengthen its position in Europe. In June 2018, Keystone Dental, Inc. signed a definitive agreement to be acquired by Accelmed (a U.S. and Israel-based investment firm majorly dedicated to value creation for medical device companies and technologies).

Periods of History and Forecast

This study report includes an analysis for each segment from 2016 to 2026, with 2017 as the base year. The compound annual growth rate (CAGR) for each of the respective segments is estimated for the forecast period from 2018 to 2026.

Report Scope by Segments

The current report also includes qualitative and quantitative market valuation factors such as key market drivers, market trends, restraints, and opportunities to provide a better understanding of the implant biomaterials market as a whole. Additionally, the global report also comprises a graphical representation of the competitive landscape based on their market initiatives and strategies, product portfolios, and business strengths.

Key questions are answered in this report.

  • What are the current market trends and dynamics in the implant biomaterials market, and what are the valuable opportunities for emerging players?
  • What is the market positioning of the major market players?
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which application holds a larger market share and why?
  • What is the impact of the high cost of implants and surgery on the global market?
  • Are low- and middle-income economies investing in the implant biomaterials market?
  • What are the market trends and dynamics in emerging markets such as Japan, Latin America, the Middle East, and Africa?

Frequently Asked Questions:

The market for Implant Biomaterials Market is expected to reach US$ 64.0 Bn by 2026.

The Implant Biomaterials Market is expected to see significant CAGR growth over the coming years, at XX%.

The report is forecasted from 2018-2026.

The base year of this report is 2017.

Evonik Industries AG, Celanese Corp., Royal DSM, Invibio, Inc., DuPont, AdvanSource Biomaterials Corp., Collagen Matrix, Inc., Invibio Ltd., Collagen Solutions Plc., Keystone Dental, Inc., Surgical are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Nov 2018
Category:  Medical Devices
Report ID:   59423
Report Format:   PDF
Pages:   120
Rating:    4.4 (56)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support